APT29 targets COVID-19 vaccine development
released on 2020-07-16 @ 04:10:42 PM
Throughout 2020, APT29 has targeted various organisations involved in COVID-19 vaccine development in Canada, the United States and the United Kingdom, highly likely with the intention of stealing information and intellectual property relating to the development and testing of COVID-19 vaccines.
APT29 is using custom malware known as ‘WellMess’ and ‘WellMail’ to target a number of organisations globally. This includes those organisations involved with COVID-19 vaccine development. WellMess and WellMail have not previously been publicly associated to APT29.